Certara

Certara FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Certara (CERT) as of Oct 18, 2026 is -4,374.23 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -493.11 % — a change of 787.07% (lower).

FCF Conversion

-4,374.23 %

YoY

787.07%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Certara is 2025 -4,374.23 % . FCF Conversion Rate (FCF/EBITDA) of Certara was 2024 -493.11 % . It decreases by 787.07% lower compared to the previous year.

The Certara FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-0.32 USD
Jan 1, 2019
-319.38 USD
Jan 1, 2020
-74.65 USD
Jan 1, 2021
-388.10 USD
Jan 1, 2022
543.17 USD
Jan 1, 2023
-121.81 USD
Jan 1, 2024
-493.11 USD
Jan 1, 2025
-4,374.23 USD
The Certara FCF Conversion history
YEARFCF ConversionYoY
-4,374.23 %+787.07%
-493.11 %+304.81%
-121.81 %-122.43%
543.17 %-239.95%
-388.10 %+419.93%
-74.65 %-76.63%
-319.38 %+99,170.96%
-0.32 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Certara Stock analysis

What does Certara do? Certara Inc. is a company specializing in the development of innovative solutions for the pharmaceutical industry. It offers a wide range of services and products to support its customers in all phases of drug development. The company was formed in 2008 through the merger of Tripos International and Pharsight Corporation. It combines expertise in software development, modeling and simulation, and offers solutions to the pharmaceutical industry's challenges. Certara provides services in modeling and simulation, analysis software development, pharmacokinetics, and regulatory support. Its products include software solutions like Knowledgebase for Clinical Trials, Phoenix modeling software, and Simcyp analysis software. The company also offers training and educational programs to provide customers with necessary knowledge. Certara focuses on integrity, transparency, and scientific approach in its offerings. Certara is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Certara stock

FCF Conversion Rate (FCF/EBITDA) of Certara is -4,374.23 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Certara changed from -493.11 % to -4,374.23 %, representing a 787.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Certara since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Certara with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Certara

All Key Metrics — Certara